Zimbabwe has formally withdrawn from negotiations over a proposed $367 million health funding agreement with the United States, describing the offer as “lopsided” and incompatible with the principles of sovereign partnership. The decision, announced by government spokesperson Nick Mangwana on February 25, follows what officials characterized as a comprehensive inter-ministerial review of the draft arrangement.

According to Mangwana, the southern African nation concluded that the terms of the five-year agreement were asymmetrical and did not provide adequate guarantees of reciprocal benefit. At the heart of the dispute were provisions requiring Zimbabwe to share biological resources and epidemiological data with Washington over an extended period, without firm assurances of access to any resulting medical innovations.

“At its core, the proposal was asymmetrical,” Mangwana said. “Zimbabwe cannot accept unequal conditions that would compel us to share sensitive biological resources and national health data without clear, enforceable guarantees of benefit-sharing.”

The proposed package, described by the US Embassy in Harare as potentially the largest single health investment in Zimbabwe by any international partner, would have supported priority public health programs. These included HIV/AIDS treatment and prevention initiatives, tuberculosis control, malaria response efforts, and maternal and child health services.

In a statement issued on February 24, the US Embassy expressed regret over Harare’s decision, calling it “deeply disappointing.” The embassy noted that the agreement would have provided substantial financial and technical support to Zimbabwe’s health sector over five years.

US Ambassador Pamela Tremont underscored the potential human impact of the breakdown in talks. “This collaboration would have delivered extraordinary benefits for Zimbabwean communities – especially the........

© Blitz